REFERENCE
Rogers G, Garside R, Mealing S, Pitt M, ANDERSON R, Dyer M, Stein K, Somerville M.Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. PharmacoEconomics 26: 33-44, No. 1, 2008
Rights and permissions
About this article
Cite this article
Carmustine implants costly in high-grade gliomas. Pharmacoecon. Outcomes News 544, 5 (2008). https://doi.org/10.2165/00151234-200805440-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805440-00009